The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-tert-butyl-N-(2-fluoro-4-(2-(1-(2-morpholinoethyl)-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl)benzyl)-1,2,4-oxadiazole-5-carboxamide ID: ALA4878102
PubChem CID: 121250008
Max Phase: Preclinical
Molecular Formula: C29H32FN9O3
Molecular Weight: 573.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5cnn(CCN6CCOCC6)c5)nc34)cc2F)n1
Standard InChI: InChI=1S/C29H32FN9O3/c1-29(2,3)28-36-27(42-37-28)26(40)32-15-19-5-4-18(14-22(19)30)21-6-7-31-25-23(21)34-24(35-25)20-16-33-39(17-20)9-8-38-10-12-41-13-11-38/h4-7,14,16-17H,8-13,15H2,1-3H3,(H,32,40)(H,31,34,35)
Standard InChI Key: JAOZSTQBDRTAJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
9.3234 -3.7888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5380 -4.5812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1170 -3.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3227 -7.6436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3216 -8.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0296 -8.8721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7393 -8.4627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7364 -7.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0278 -7.2347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0313 -9.6871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3219 -10.0949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3213 -10.9114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0294 -11.3209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7367 -10.0931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7440 -10.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5215 -11.1532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9948 -10.4894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5097 -9.8343 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8120 -10.4821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3007 -11.1365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0756 -10.8770 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0682 -10.0598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2888 -9.8144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4426 -7.2287 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.0254 -6.4175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7319 -6.0068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7294 -5.1896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0205 -4.7832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4359 -4.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1804 -5.1082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7254 -4.4993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3147 -3.7928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5159 -3.9652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8730 -5.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7250 -9.5735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4745 -9.8991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1312 -9.4128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8776 -9.7407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5326 -9.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4440 -8.4453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6943 -8.1176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0334 -8.6025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 15 1 0
14 10 1 0
6 10 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
17 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 19 2 0
8 24 1 0
9 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
27 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 29 1 0
31 2 1 0
2 34 1 0
22 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
37 42 1 0
38 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 573.63Molecular Weight (Monoisotopic): 573.2612AlogP: 3.57#Rotatable Bonds: 8Polar Surface Area: 139.88Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.35CX Basic pKa: 6.87CX LogP: 3.57CX LogD: 3.41Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.29Np Likeness Score: -2.00
References 1. Qiu H, Ali Z, Bender A, Caldwell R, Chen YY, Fang Z, Gardberg A, Glaser N, Goettsche A, Goutopoulos A, Grenningloh R, Hanschke B, Head J, Johnson T, Jones C, Jones R, Kulkarni S, Maurer C, Morandi F, Neagu C, Poetzsch S, Potnick J, Schmidt R, Roe K, Viacava Follis A, Wing C, Zhu X, Sherer B.. (2021) Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitors., 40 [PMID:33932711 ] [10.1016/j.bmc.2021.116163 ]